Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Biochemical analysers to move out of the lab:

This article was originally published in Clinica

Executive Summary

The emergence of next-generation biochemical analysers has edged a step closer, as The University of Texas MD Anderson Cancer Center closed a commercial and development deal with Applied MEMS, specialists in micro-electrical mechanical systems. The collaborators plan to develop a handheld, portable device that integrates fluidics, optics and sensing techniques onto a single silicon chip, reducing the cost and inconvenience associated with laboratory-based equipment. Applied MEMS, of Stafford, Texas, will develop and manufacture the micro-fluidic processor chips, while aDEPtas, a spin-off from MD Anderson, will commercialise the product.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT059731

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel